News - Appointments

Larry Bell joins Prosensa Therapeutics

Read more

Edwin Klumper becomes CEO of SMS-oncology

Read more

Peter Garnett joins Crimson & Co

Read more

Jan Nilsson becomes COO at NeuroVive

Read more

Michael Whitaker joins board of UK Cell Therapy Catapult

Read more

Hans Wijers becomes non-executive director at GSK

Read more

Philip Barter joins Dezima science board

Read more

Philip Astley-Sparke joins UniQure

Read more

John Reed joins Roche executive committee

Read more

Barbara Jaszewski to lead market access at Lundbeck

Read more